SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022
Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 Engels-et-al-2023
%A Engels, G.
%A Oechsle, A. L.
%A Schlegtendal, A.
%A Maier, C.
%A Holzwarth, S.
%A Streng, A.
%A Lange, B.
%A Karch, A.
%A Petersmann, A.
%A Streeck, H.
%A Blaschke-Steinbrecher, S.
%A Härtel, C.
%A Schroten, H.
%A von Kries, R.
%A Berner, R.
%A Liese, J.
%A Brinkmann, F.
%A Toepfner, N.
%D 2023
%J Infection
%K affiliation:ikeb author:heuschmannpu author:kohlsm author:reesejp author:rueckerv from:nuernbergerc project:immunebridge project:nukleusecu
%N 5
%P 1531-1539
%R 10.1007/s15010-023-02052-5
%T SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022
%V 51
@article{Engels-et-al-2023,
added-at = {2023-10-09T15:22:22.000+0200},
author = {Engels, G. and Oechsle, A. L. and Schlegtendal, A. and Maier, C. and Holzwarth, S. and Streng, A. and Lange, B. and Karch, A. and Petersmann, A. and Streeck, H. and Blaschke-Steinbrecher, S. and Härtel, C. and Schroten, H. and von Kries, R. and Berner, R. and Liese, J. and Brinkmann, F. and Toepfner, N.},
biburl = {https://www.bibsonomy.org/bibtex/2326c023cfa59abf60ff9a024e2a461f0/ike-b_uniwue},
doi = {10.1007/s15010-023-02052-5},
interhash = {14365c915d9bf8e708aed517c70291d1},
intrahash = {326c023cfa59abf60ff9a024e2a461f0},
issn = {0300-8126 (Print)
0300-8126},
journal = {Infection},
keywords = {affiliation:ikeb author:heuschmannpu author:kohlsm author:reesejp author:rueckerv from:nuernbergerc project:immunebridge project:nukleusecu},
number = 5,
pages = {1531-1539},
timestamp = {2024-05-21T11:13:28.000+0200},
title = {SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022},
type = {Journal Article},
volume = 51,
year = 2023
}